Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2025 Jan 6;157(1):e20171197912022024c.
doi: 10.1085/jgp.20171197912022024c. Epub 2024 Dec 19.

Correction: Toward an understanding of the structural basis of allostery in muscarinic acetylcholine receptors

Wessel A C Burger, Patrick M Sexton, Arthur Christopoulos, David M Thal
Published Erratum

Correction: Toward an understanding of the structural basis of allostery in muscarinic acetylcholine receptors

Wessel A C Burger et al. J Gen Physiol. .
No abstract available

PubMed Disclaimer

Erratum for

References

    1. Bodick, N.C., Offen W.W., Levey A.I., Cutler N.R., Gauthier S.G., Satlin A., Shannon H.E., Tollefson G.D., Rasmussen K., Bymaster F.P., et al. . 1997. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch. Neurol. 54:465–473. 10.1001/archneur.1997.00550160091022 - DOI - PubMed
    1. Kruse, A.C., Kobilka B.K., Gautam D., Sexton P.M., Christopoulos A., and Wess J.. 2014. Muscarinic acetylcholine receptors: novel opportunities for drug development. Nat. Rev. Drug Discov. 13:549–560. 10.1038/nrd4295 - DOI - PMC - PubMed
    1. Shekhar, A., Potter W.Z., Lightfoot J., Lienemann J., Dubé S., Mallinckrodt C., Bymaster F.P., McKinzie D.L., and Felder C.C.. 2008. Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. Am. J. Psychiatry. 165:1033–1039. 10.1176/appi.ajp.2008.06091591 - DOI - PubMed

Publication types

LinkOut - more resources